Floatz logo

Folic Acid

Thalassemia

Fakultas Kedokteran Universitas IndonesiaSmall moleculePhase 4 / ApprovedDormant
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
89/ 100

Competitive context

24 Active assets in the Thalassemia cohort.

Asset / SponsorPhaseRating
Deferasirox
Novartis Pharmaceuticals
Phase 4BBB
Hydroxyurea
Riphah International University
Phase 4BB
Fludarabine
Memorial Sloan Kettering Cancer Center
Phase 2/3BB
Etavopivat
Novo Nordisk A/S
Phase 3BB
ZINC SULFATE
Fakultas Kedokteran Universitas Indonesia
Phase 4BB

View all 50 →

Same molecule, other indications

Folic Acid is also rated in:

hyperhomocysteinemiaDormant
BBB
Indicative ·
76 / 100
View asset →
myocardial infarctionDormant
BBB
Indicative ·
72 / 100
View asset →
polycystic ovary syndromeDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →